Eliquis 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FAWHK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,869
Award facts
- Contract value 100% obligated
- $13,869.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,869.41 to DMS Pharmaceutical Group Inc. for the supply of Eliquis 5 mg tablets (60-count units) on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price delivery order represents a standalone procurement under DLA's pharmaceutical supply operations, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a woman-owned small business pharmaceutical wholesaler.
DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, holds a significant position within the federal pharmaceutical supply chain through its $499,999,999 Indefinite Delivery Contract with DLA under the SPE2DB program, valid through November 2026. This delivery order for Eliquis—a prescription anticoagulant medication—exemplifies the company's core business of distributing branded and generic prescription drugs to military and federal healthcare facilities nationwide. The company's robust portfolio of federal contract awards demonstrates its established capability in delivering comprehensive pharmaceutical products, including specialty medications and biologics, directly supporting Department of Defense healthcare requirements across military installations worldwide.
Quick answers
Who was awarded contract SPE2DB25FAWHK?
SPE2DB25FAWHK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FAWHK worth?
The government has obligated $13,869 on SPE2DB25FAWHK.
Is contract SPE2DB25FAWHK an order under another contract?
Yes. SPE2DB25FAWHK is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAWHK competed?
The extent of competition for SPE2DB25FAWHK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award